MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation ROE Ratio 2011-2026 | DHR
Annual ROE Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.88 | 7.87 | 8.91 | 14.39 | 14.24 | 9.17 | 9.93 | 9.39 | 9.45 | 11.07 | 14.13 | 11.08 | 12.0 | 12.54 | 12.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.39 | 6.88 | 10.92 |
Quarterly ROE Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.95 | 5.64 | 9.25 | 10.93 | 9.99 | 12.66 | 13.23 | 10.61 | 12.83 | 12.38 | 10.54 | 6.05 | 10.2 | 10.18 | 10.27 | 9.87 | 8.37 | 8.52 | 8.49 | 9.4 | 10.0 | 9.82 | 9.54 | 9.45 | 9.45 | 8.98 | 9.72 | 11.1 | 10.76 | 14.98 | 15.06 | 14.17 | 14.1 | 11.08 | 11.04 | 11.11 | 11.81 | 11.57 | 11.43 | 12.04 | 11.83 | 12.05 | 12.45 | 12.58 | 12.64 | 12.85 | 13.53 | 12.85 | 3.1 | 3.84 | 2.54 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.06 | 2.54 | 10.45 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 201.42 | -0.84 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 87.16 | -1.57 % | $ 4.08 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 4.0 | -6.76 % | $ 5.32 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 20.83 | 0.63 % | $ 604 M | USA |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 18.67 | -0.05 % | $ 575 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
419.21 | $ 131.64 | 0.02 % | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 23.44 | 2.02 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 146.34 | 0.11 % | $ 11.5 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.64 | 2.19 % | $ 7.26 M | USA |
 |
Illumina
ILMN
|
31.22 | $ 165.6 | 2.88 % | $ 25.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 104.33 | -0.18 % | $ 7.04 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 190.08 | 1.37 % | $ 9.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 468.18 | 0.18 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 152.81 | 2.1 % | $ 23.8 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 4.31 | -0.58 % | $ 399 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 11.08 | -0.63 % | $ 1.42 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.37 | -2.24 % | $ 411 M | USA |
 |
Natera
NTRA
|
-12.16 | $ 215.44 | 1.59 % | $ 29.5 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.99 | $ 1.39 | 5.73 % | $ 417 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 9.99 | 4.17 % | $ 892 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 26.73 | 1.0 % | $ 25.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 7.27 | 1.18 % | $ 303 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.01 | -1.95 % | $ 4.62 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.91 | -0.74 % | $ 22 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 80.85 | 6.14 % | $ 4.84 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 472.33 | 0.74 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.66 | 1.0 % | $ 237 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.1 | -0.05 % | $ 1.97 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |